Navigation Links
Delcath To Offer Second Generation Hemofiltration Cartridge In U.S. Expanded Access Program
Date:6/18/2012

NEW YORK, June 18, 2012 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH) today announced that the Company has amended its Investigational New Drug (IND) application and its Expanded Access Program (EAP) to include the use of the second-generation hemofiltration cartridge of the Company's proprietary chemosaturation system. The amendments filed with the U.S. Food and Drug Administration (FDA) will permit physicians to use the second-generation system in expanded access and compassionate use cases in selected cancer centers trained in the use of the Delcath system. The amendments also permit the use of the second-generation system in clinical trials the Company has planned as part of its Clinical Development Program. Previously, only the first-generation system used in Delcath's clinical trials was available for individual compassionate use cases.

Under the Expanded Access Protocol, eligible patients will be able to receive treatment through enrollment at participating cancer centers. These centers will be able to begin treating patients upon receipt of institutional review board (IRB) approval which the company expects most centers will receive in the third quarter of 2012.

The second-generation hemofiltration cartridge has demonstrated greater efficiency in melphalan removal from the blood in bench-top and in vivo porcine studies. The Company believes that if filtration efficiency is validated in clinical use, the second-generation system may significantly reduce melphalan-associated bone marrow toxicity noted in prior clinical trials.

"We believe it is in the best interest of patients to accelerate availability of the second generation filter for investigational uses in the U.S.," said Eamonn P. Hobbs, President & CEO of Delcath Systems. "We are encouraged by the reports on initial patient treatments in Italy and Germany, where physicians h
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Systems, Inc. Secures $20 Million Credit Facility
2. Delcath Highlights First Quarter 2012 And Recent Accomplishments
3. Delcath to Webcast Managements Presentation at Annual Meeting of Stockholders
4. Delcath Prices $20 Million Public Offering of Common Stock and Warrants
5. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
6. Two Top Notch Cadaver Workshops Offered by joimax® in April
7. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
8. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
9. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
10. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
11. Genesis Biopharma Announces Termination of Previously Announced Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Eli Lilly and ... AZN ) today announced that they have entered into ... preliminary efficacy of AstraZeneca,s investigational anti-PD-L1 immune checkpoint inhibitor, ... VEGF Receptor 2 antiangiogenic cancer medicine. The planned study ... with advanced solid tumors. The Phase I ...
(Date:5/28/2015)... and Company (NYSE: LLY ) announced today the pricing ... to $1.6 billion aggregate principal amount of certain of its ... and did not validly withdraw, their notes on or before ... on May 27, 2015 (the early tender date), and which ... the total consideration. The total consideration for each series of ...
(Date:5/28/2015)... Research and Markets ( ... Jain PharmaBiotech,s new report  "RNAi - Technologies, ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... the use of double stranded RNA (dsRNA). ... processed into short 21-23 nucleotide RNAs termed ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3
(Date:5/29/2015)... On May 21, 2015, Elle Magazine in ... Get Botox ?” reported on the four most commonly ... with Google to determine these results and then sought expert ... California, for example, is how to keep neck skin ... is what's the appropriate age to start receiving Botox ...
(Date:5/29/2015)... Red Hot & Blue Restaurants , Inc. President, ... restaurant at 525 New Waverly Place in Cary, North Carolina ... Hot & Blue Restaurant was previously located in this very ... to a new location in the center,” said McCann. He ... activities on the Promenade–with outdoor seating and service, next to ...
(Date:5/29/2015)... Jan Wooden Howse lost her husband and ... all else: God does no wrong. , It’s fitting, then, ... passing is titled “God Does No Wrong.” It focuses on ... personal tragedy. , “My story has a positive message ... into something productive, something healing,” Howse said. , “God Does ...
(Date:5/29/2015)... 2015 To compile the list, the ... that have several awards for clinical and general excellence. ... stood out to them in terms of overall excellence, ... , The 50 Great Health Systems to Know 2015 ... (Altamonte Springs, Fla.) , Advocate Health Care (Downers Grove, ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 ... have reached a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ... developed gynecomastia due to his use of the ... had been selected for the third bellwether trial ... mass tort litigation underway in Pennsylvania’s Philadelphia Court ...
Breaking Medicine News(10 mins):Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Turning grief from a child’s passing into virtue 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... ... before and after photos , ... 9, 2010 -- HCG True Diet offers new HCG Diet before and after photos and revamped ... navigation bar at the left hand of the site. The photos are taken of a ...
... HealthDay Reporter , THURSDAY, July 8 (HealthDay News) -- The ... smoke has slowed significantly, following dramatic drops starting in the ... percent of high school students still smoke, making it impossible ... among teens to 16 percent or less, the U.S. Centers ...
... ... career opportunities for ambitious professionals. , ... (PRWeb UK) July 9, 2010 -- HCL International, the leading global health and social ... GPs and social workers interested in working in Australia, at an invitation-only ...
... ... discovered a different kind of healing through writing down her emotions , ... Honolulu, HI (Vocus) July 9, 2010 -- She ... the release of Finally, it’s my time!, her new book made available through Xlibris, author ...
... ... new ways to make extra cash without having to spend big dollars. ... and beauty”. While most people cut back on certain luxuries during hard ... the recession. Youthful Trends is an innovative cosmetic company that is banking ...
... obese children have a 40 percent higher risk of ... obese have a 30 percent higher risk of GERD ... Permanente study published online in the International Journal ... establishes an association between obesity and GERD in children, ...
Cached Medicine News:Health News:See New HCG Diet Before and After Photos 2Health News:Decline in U.S. Teen Smoking Rate Stalls 2Health News:Decline in U.S. Teen Smoking Rate Stalls 3Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 2Health News:HCL International: Australia a Favourite Destination for UK Social Workers and GPs 3Health News:Moving On With A Pen 2Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 2Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 3Health News:Natural Cosmetic Company Offers Women Entrepreneurs a New Way to Make Money in Hard Times 4Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 2Health News:Extremely obese children have 40 percent higher risk of reflux disease of esophagus 3
Free Estriol (E3) RIA Reproductive Hormones 024-IDC-2000...
Prolactin EIA Reproductive Markers 025-BC-1037...
... (17aOHP) is produced by both the ... has relatively little progestational activity, it ... it is the,immediate precursor to 11-desoxycortisol ... 21-hydroxylation of 17aOHP,measurement of 17aOHP is ...
FSH EIA Reproductive Markers 025-BC-1029 Follicle Stimulating Hormone...
Medicine Products: